Alice G. Willison

Duesseldorf, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Treatment approaches to patients with multiple sclerosis and coexisting psoriasis - A longitudinal multicenter observational cohort study.

Treatment approaches to patients with multiple sclerosis and coexisting psoriasis - A longitudinal multicenter observational cohort study.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: February 20, 2026

Altered network recruitment in multiple sclerosis patients during resting state.

Altered network recruitment in multiple sclerosis patients during resting state.

Journal: Multiple sclerosis and related disorders

Published: August 22, 2025

Flow cytometry identifies changes in peripheral and intrathecal lymphocyte patterns in CNS autoimmune disorders and primary CNS malignancies.

Flow cytometry identifies changes in peripheral and intrathecal lymphocyte patterns in CNS autoimmune disorders and primary CNS malignancies.

Journal: Journal of neuroinflammation

Published: September 15, 2024

Differences in innate immune cell populations distinguish autoimmune from herpesvirus-associated encephalitis.

Differences in innate immune cell populations distinguish autoimmune from herpesvirus-associated encephalitis.

Journal: Journal of autoimmunity

Published: August 29, 2024

Lymphocyte signatures correspond to clinical phenotypes in autoimmune limbic encephalitis.

Lymphocyte signatures correspond to clinical phenotypes in autoimmune limbic encephalitis.

Journal: Brain communications

Published: July 29, 2024

Ofatumumab-induced severe reactivation of psoriasis in a patient with multiple sclerosis.

Ofatumumab-induced severe reactivation of psoriasis in a patient with multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: June 15, 2024

Different Treatment Outcomes of Multiple Sclerosis Patients Receiving Ocrelizumab or Ofatumumab.

Different Treatment Outcomes of Multiple Sclerosis Patients Receiving Ocrelizumab or Ofatumumab.

Journal: Annals of neurology

Published: April 08, 2024

Preventing long-term disability in CIDP: the role of timely diagnosis and treatment monitoring in a multicenter CIDP cohort.

Preventing long-term disability in CIDP: the role of timely diagnosis and treatment monitoring in a multicenter CIDP cohort.

Journal: Journal of neurology

Published: March 15, 2024

Inter-alpha-trypsin inhibitor heavy chain H3 is a potential biomarker for disease activity in myasthenia gravis.

Inter-alpha-trypsin inhibitor heavy chain H3 is a potential biomarker for disease activity in myasthenia gravis.

Journal: Acta neuropathologica

Published: February 15, 2024

"A second birthday"? Experiences of persons with multiple sclerosis treated with autologous hematopoietic stem cell transplantation-a qualitative interview study.

"A second birthday"? Experiences of persons with multiple sclerosis treated with autologous hematopoietic stem cell transplantation-a qualitative interview study.

Journal: Frontiers in neurology

Published: February 09, 2024

SARS-CoV-2 Vaccination and Neuroimmunological Disease: A Review.

SARS-CoV-2 Vaccination and Neuroimmunological Disease: A Review.

Journal: JAMA neurology

Published: January 16, 2024

The Use of Nitrosative Stress Molecules as Potential Diagnostic Biomarkers in Multiple Sclerosis.

The Use of Nitrosative Stress Molecules as Potential Diagnostic Biomarkers in Multiple Sclerosis.

Journal: International journal of molecular sciences

Published: December 02, 2023

Showing 1-12 of 32

Last Updated: 09/26/2026